Prophylactic treatment of bleeding episodes in children
Sign Up to like & getrecommendations! Published in 2018 at "Haemophilia"
DOI: 10.1111/hae.13500
Abstract: Hereditary factor X (FX) deficiency (FXD) affects 1:500 000‐1:1 000 000 people worldwide. A novel, high‐purity plasma‐derived FX concentrate (pdFX) is available in the United States and European Union as replacement therapy for FXD, but… read more here.
Keywords: fxd; hereditary factor; deficiency fxd; pdfx ... See more keywords
A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency
Sign Up to like & getrecommendations! Published in 2022 at "Haemophilia"
DOI: 10.1111/hae.14570
Abstract: Hereditary factor X (FX) deficiency (FXD) is a rare autosomal recessive bleeding disorder. Plasma‐derived FX (pdFX) is a high‐purity FX concentrate approved in the United States and Europe for the treatment and prophylaxis of bleeding… read more here.
Keywords: factor; hereditary factor; high purity; factor deficiency ... See more keywords